编者按：慢性乙型肝炎（CHB）是全球重大健康问题，每年导致超过 82万人死亡，其中大部分是由于病毒感染相关肝硬化和肝细胞癌（HCC）所造成。在CHB感染的不同阶段，乙型肝炎表面抗原（HBsAg）和e抗原（HBeAg）水平的血清学特征随之发生变化。在CHB患者中，HBeAg阳性且HBsAg低水平的患者虽占比较少，但疾病风险不容忽视。既往研究表明，该类患者可能与显著肝纤维化、肝硬化及肝癌风险增加有关， ...

Researchers update clinical practice guidelines for how to prevent and monitor hepatitis B virus reactivation.

Detailed chart review was performed to identify all patients who were administered HBV vaccine within 180 days prior to HBsAg testing and also to ascertain likely cause of weakly positive ...

We similarly followed 16 children of hepatitis B surface antigen (HBsAg)-positive mothers. Results: Of low risk infants receiving a plasma-derived vaccine, 41% (42 of 102) of those whose primary ...

showing significant reductions in HBsAg levels compared to placebo. Preliminary data from an additional cohort receiving imdusiran, VTP-300, and low doses of nivolumab are expected in the second ...